This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignee: University of Utah Research Foundation. Active years: 2014-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2023
Title: Russell Morris Condie: Innovator in Medical Imaging and Eosinophilic Disease Diagnosis
Introduction
Russell Morris Condie is a notable inventor based in Salt Lake City, UT. He has made significant contributions to the field of medical imaging and the diagnosis of eosinophilic diseases. With a total of 5 patents to his name, Condie's work has the potential to impact patient care and treatment outcomes.
Latest Patents
Among his latest patents, Condie has developed a method for detecting eosinophil degranulation in the respiratory tract. This innovative approach includes administering radiolabeled heparin to the respiratory tract, which binds to eosinophil granule proteins in the mucosal tissue. Additionally, he has disclosed methods for diagnosing and monitoring eosinophilic esophagitis, providing valuable tools for healthcare professionals to assess and treat this condition effectively.
Career Highlights
Condie is affiliated with the University of Utah Research Foundation, where he continues to advance his research and innovations. His work is characterized by a commitment to improving diagnostic methods and enhancing medical imaging techniques.
Collaborations
Some of his notable coworkers include Leonard F Pease and Hedieh Saffari, who have contributed to his research endeavors.
Conclusion
Russell Morris Condie's contributions to medical imaging and eosinophilic disease diagnosis exemplify the impact of innovation in healthcare. His patents reflect a dedication to improving patient outcomes through advanced diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
